15th European Molecular Imaging Meeting
supported by:

To search for a specific ID please enter the hash sign followed by the ID number (e.g. #123).
Keyword Contributions
11c-methylation 112
13c -labeled tracer #557
13c mrs PS 23-03
13c nmr PS 23-03
13c-labeled tracer PS 02-06
18f PS 05-03
18f-fdg PS 08-02
18f-fdg pet 127
18f-fdg pet/ct 172
18f-fdg-pet PS 06-04
18f-fluoronaphthol #35
18f-flurolactate PS 08-02
18f-fmiso 177PS 08-07
19f PS 08-04#465
19f mri PS 08-04PS 08-04#395
19f-mri PS 08-04126
2-nitroimidazole PL 07
2-photon imaging PS 24-03
2h fumarate PL 05
31p magnetic resonance imaging #11
31p magnetic resonance spectroscopy #11
3d image registation #319
3d imaging PS 19-03
3d live imaging 111
3d live tracking. #367
3r #466
5-ht1a receptors PS 23-02
52-mn #92
5d ct PS 02-02
62zn PS 05-03
68ga #40129
68ga-dkfz-psma-11 112
68ga-dota-cdp1 129
68gadfo 129
89zr PS 09-07
90y-dota-psma-d4 #311
99mtc-mibi 119
99mtc-radiotracer 113113
[11c]ucb-j 191128
[18f]cf4 PS 08-03
[18f]cinacalcet 112
[18f]dpa-714 pet #33PS 21-03
[18f]faza PL 06
[18f]fluda #263130
[18f]fluoroform 112
[18f]fluorothymidine 191103
[18f]frpg PS 08-07
[18f]fspg PS 08-07
[18f]ge180 PS 21-03
[18f]psma-1007 100
[68ga]-ubi 129
a2ar 130
abdominal aortic aneurysm 191PS 08-06103
acetazolamide #413
acetylcholine #325PS 23-02
acini PS 08-06
acquatic animal imaging #45
acute cardiomyopathy induced by stress 130
acute respiratory distress syndrome 178PS 21-02
adenosine 130
adenosine 2a receptor 102
adenosine a2a receptor #263
adept #250
administration routes #233
advanced imaging facilities #726
affibody PS 23-05
aging #385
aif PS 08-03
akt1 kinase 129
alf-18 179112
alk5 PS 23-04
alpha-emitters PS 07-04
alpha-synuclein 128
als 127
alternativ animal model #320
alzheimer PS 08-03
alzheimer disease PS 10-02
alzheimer disease model 102
alzheimer model 102
alzheimer' disease 128
alzheimer's disease PS 01-05PS 09-03102#237
alzheimer's mouse model 127
alzheimer’s disease PS 09-03
ambroxol 127
amino acids 113
amphipathic peptide 126
amphotericin b 178PS 05-04#257
amyloid PS 01-05#222
amyloid plaques PS 09-03
amyloid-beta PS 09-03128
anesthesia PS 23-02PS 23-03#576PS 24-03
aneuploidy PL 06
angiogenesis #357
angiography PS 23-06128
angiotensin ii 191103
animal PL 06
animal model PS 01-05PL 05130
animal study #311
anthracyclines 130
anti-cancer agents #394
anti-cancer drug 101
antibiocs PS 05-06
antibiotics 178PS 05-04
antibodies #654
antibody PS 05-06PS 05-06PL 07100139
antibody modification PL 07
antibody-fragments #654
anticancer #346
antitumor metal complexes 105#216
aortic dissection 103
apoe-/- 191103
apoptosis 177PS 06-03126
aptamer 178PS 09-02
aptamers 111
arftificial intelligence PS 08-06
arterial tacs 179#291
arthritis #466
artifacts #54
ascending aorta aneurysms 103
asthma mouse model #393
astrocytes 127
asymmetric radiosynthesis 113
atherosclerosis PS 22-05PS 23-04PS 08-04#40103104
atherosclerotic plaque 104
atlas creation 109
atlas registration 111
au nanocluster #206
auditory processing #591PS 08-03
autism spectrum disorder PS 10-02
automation #163
autoradiography PS 01-05PS 01-05
avb6 101
awake PS 24-03PS 24-03
axr #57
aza-bodipy 139
azd2461 192100
azd3965 PS 08-02
background correction PS 08-06
backscattering PL 07
bacterial infection PS 05-06
barrett's oesophagus 177PS 09-07
basal cell carcinoma PL 06
basal forebrain cholinergic system #325PS 23-02
bbb PS 09-02
bbmri #751
beam hardening 193#148
behavior 111#367
behaviour PS 24-03
bevacizumab PS 06-03
biased agonist PS 23-02
bicuspid aortic valve 103
bimodal 177PS 08-02
bimodal imaging 139139
bimodal mri/pet #92
bimodality 179105105
binding assay 111
biobanking #751
bioconjugation PS 05-03
biodistribution 100128
bioimaging #688#684#273#388#112
bioimaging austria #746
bioluminescence imaging #504
bioluminescence tomography PS 07-04
biomarker 192PL 05PS 05-02#212#54
biomarkers 100
biosensors PS 18-06
biotin 111
bispidine #92
bladder segmentation 100
bleomycin #576
blood brain barrier 127
blood flow #374PS 05-06
blood pressure radiotelemetry 139
blood vessels permeability #357
blood-brain barrier 128
bodipy PS 06-05
bold oscillations 109
bold-fmri PS 22-03
bone formation 104
bone healing PS 10-02
bone model PS 09-07
boron vectorization 192101
brain PS 05-06PS 06-04102128
brain atlas 109#416
brain cancer PL 06
brain perfusion #374PS 05-06
brain slice 109
brain tumor PS 08-03
brain tumors 112
brain-targeted delivery system 112
brainstate #413
breast cancer 193PS 19-03PS 23-05PS 06-03PL 06#58
breast imaging 193#58
breast tissue cancer 100
bronchial wall thickness PS 07-04
brown adipose tissue PS 06-04
bruker PS 10-02
bssfp 193#252PS 02-06
burst suppression PS 23-02
c. elegans #385
calcification PS 05-03
calcifications PS 21-03
calcium PS 23-04PS 08-04
calcium fluoreescence imaging 127
calcium imaging PS 09-03
calibration 111
cancer 192PS 22-05PS 22-05PS 05-02100100111126139#427PS 24-02#618PS 02-06
cancer cell spheroids #472
cancer imaging PS 08-07PS 08-07126
cancer immunotherapy PS 05-02
cancer surgery 193#197
cancer therapy 101
candida albicans 129
caps camera PS 23-07
carbon monoxide #127
carbon-11 PS 01-02112113
carbonic anhydrase ix PS 08-07
cardiac 105PS 01-04
cardiac function PS 10-02
cardiac imaging PS 21-02
cardiac mri #205
cardiac remodeling PS 01-04
cardiogenic shock PS 09-02
cardiomyopathy PS 23-04PS 01-04
cardiotoxicity 130
cardiovascular 112#686
cardiovascular disease PS 23-06103
cardiovascular diseases #405
carotid artery 193#457
carotid atherosclerosis 103
cd4 t cells PS 05-02
cd47 126
cd8 #495
cd80 PS 23-05
cell death 177PS 06-03
cell labelling 112
cell surface receptor PS 01-02
cell therapy 105127
cell tracking PS 06-05105
cell-penetrating peptides PL 07
cerebral ischemia PS 08-03PS 09-03
cerebral malaria #374PS 05-06
cerebral metabolism PS 23-03
cerebrovascular 178PS 09-03
cerenkov imaging PS 08-07#181
cerenkov luminescence imaging 193#197
cerenkov luminescence imaging (cli) #311
cest PS 06-04111#613
cest quantification 111
cest-mri 111
chelation #407
chemical delivery system 112
chemistry PS 05-03
chemokine receptor PS 22-05
chemokines PS 22-05
chemoresistance 101
chemosensitivity PL 06
chemotherapeutics #394
chemotherapy 101
choline metabolism #205
chronic bronchitis PS 07-04
chronic pain 127
chronic stage 127
cisplatin PL 07PL 06#714
classification study 100
clemastine 191#46
click chemistry 192PL 07PL 07
click-chemistry #321
clinical ct #25
clinical isolates 130
clinical translation PS 06-03PS 24-02#647
clinical trial 177PS 23-07PS 06-03PS 24-02
clinical trials 177PS 09-07139
clustering 111
cmr 191130
cochlea 109
cognition PS 24-03
coincidence time resolution 119
collagen based scaffold 128
collagen organization 128
collimator PS 01-06
colon cancer PL 06111
colorectal cancer PS 06-03125
colorectal cancer subtypes PS 05-02
companion diagnostics PS 06-03
compartment modelling 100
compton camera PS 08-03
computed tomography PS 05-04PS 02-02
comulis 168#746
cone trajectory 178PS 23-03
confocal PL 06
congenital hyperinsulinism #336
conjugated polymer nanoparticles #273#440#388
conjugation #150
connexin #237
contrast agent 176PS 01-02#321#303104105
contrast agents 176PS 08-04#25#255#20#558
contrast enhanced ultrasound 192125
contrast media PS 21-02
contrast-enhanced computer tomography #222
contrast-enhanced ultrasound imaging 176PS 06-05
copd PS 07-04
core-modifications PS 01-02
corioallantoic membrane #370
coronary arteries PS 21-02
coronary artery disease PS 22-05
correlative cryo-imaging PS 22-06
cost-effectiveness 172
cpg2 #250
crc mouse models PS 05-02
crc stratification PS 05-02
crispr/cas9 PL 05
croconaine nanoparticles PS 08-03
crohn's disease PS 08-03
cryo-em #723
cryopreservation #704
csf #413#421
csf-1r #33PS 23-05PS 21-03
ct PS 01-05#320
ct filters 111
ct imaging #393
ct-fmt imaging PL 06#275
cu-64 PL 07#714
cuprizone 191#46
curprizone 102
cxcr4 PS 22-05PS 22-05PS 22-05
cyanine dyes 112
cyanine-graphene hybrids #487
cyanines #165
d2 receptor PS 23-02
darpins 125
data analysis PL 06
data processing 111
data quantification 178PS 08-06
dce 111
dce-mri 102
ddnp PS 23-03
deconvolution 111
deep learning PS 08-06111
deep learning for ct PS 02-02
default mode network #325PS 23-02
demyelination 191102#46
dendrimer PL 07
density 102
desferrioxamine b 129
desferrioxamine derivative 176PS 05-03
desi PS 06-04#635
deuterium 176PS 05-02PS 06-04
deuterium metabolic imaging PL 05
dfo* PS 09-07
diagnosis 100
differentiation 100
diffusion #391
dimeric pesin conjugates #84
disorder strength PL 07
dispersion PS 08-03
dnp PS 06-04
dominant follicle selection #357
donepezil #237127
dopamine PL 05
dopamine receptors expression changes PL 05
dosimetry 111
dota 128
down syndrome 103127
doxorubicin 125128#512
dp1tyb model 127
dpa-714 PS 23-05
dreadds #325PS 23-02
drug delivery particles #583
drug development #628
drug discovery #635
drug efficiency evaluation #394
drug release PS 06-05
drugs-lipiodol emulsions 105
dti 191102127
dual labeling PS 23-07
dual-isotope imaging PS 07-04
dual-labeling #151
dwarf shrimp 111#372#367
dwi #424
dyes PS 09-02
dynamic acquisition PL 06
dynamic ct imaging PS 02-02
dynamic functional connectivity 102
dynamic imaging PS 01-06
eae nhp 128
early bladder tumour detection 100
early detection 177PS 09-07
eatris eric #684
egcg modulation 103
egfr PS 23-05100113
el4 #44PS 02-06
elastin-derived peptides PS 08-02
electrophysiology PS 23-02
elemental imaging PS 05-04
embolics PS 23-06
embryo #464
emi-137 PS 23-07
emim 2020 #736PS 05-03PS 23-07PS 08-07
emim 2021 PS 11-06
emsot PS 06-03
endocarditis 130
endoscopy 177177PS 23-07PS 09-07125
enhanced permeability and retention (epr) effect 125#159
enzyme responsive mri contrast agent #250
epcam 125
epilepsy PS 08-03PS 21-03128
epr effect PL 07PL 06
eric #687#688
esophageal cancer 125
esophageal carcinoma PS 09-07
eurobioimaging #688
european research infrastructure consortium #687#684#751
ex vivo PS 23-07128
ex vivo biodistribution 104
exchange #57
exendin PS 09-07#336
exfoliated graphene #487
exosomes 109128#512
experimental autoimmune myocarditis 130
extracellular lactate PS 06-04
f-18 #163
fap #132
farewell PS 11-06
fat correction 111
fat deposition #385
fatty acid #206
fbp PS 01-03
fdg 179104#45
fdg pet 130#424
feline oral squamous cell carcinoma 192125
ferrocene derivatives 101
fexi #57
fibril orientation 128
fibroblast #132
fibroblast activation protein PS 06-03
fibrosis #211PS 23-04#249PS 01-04PS 01-04
figure making PL 06
fine-tuning PS 01-02
fish #314
fkbp12-ryr stabilizer 179#291
fli 177PS 08-07
flim #265
flt-ct PS 05-04
fluorescein #465
fluorescein angiography 109
fluorescence 179PS 23-07PS 06-05100125139#178#206#165#647
fluorescence imaging PS 04-04
fluorescence guided surgery 139
fluorescence image-guided surgery 179PS 05-02139
fluorescence imaging PS 05-04PS 08-04#583PS 01-04PS 24-02
fluorescence life-time imaging #329
fluorescence lifetime PS 23-07
fluorescence microscopy PS 09-03PL 06#275
fluorescence molecular tomography #223
fluorescence monitoring #67
fluorescence tomography PS 07-04#504
fluorescence-guided surgery 177PS 23-07PS 08-02PS 24-02#647
fluorescence-guided-surgery PS 24-02
fluorescent dyes #84
fluorescent imaging PL 06
fluorescent organic nanoparticles #112
fluorescent platform 179105
fluorescent probes #273#388
fluorescent probes for in vivo in real-time imaging 126
fluorescent proteins 129
fluorine-18 192PL 07PL 07#263
fluorogenic peptide 126
fluorophores 139
fluroine-18 PS 01-02
fmn #465
fmri PS 23-02PS 23-02PS 08-03PS 09-03PS 09-03109111#461PS 24-03
focused rf heating PS 23-03
focused-ultrasound PS 10-02
focussed ultrasound PS 09-02
formaldehyde #67
foundations PS 01-03
fret 179#178#112
fugene 105
full-wave inversion #401
fumarate PS 23-03
functional connectivity 191191PS 22-03PS 23-02109127
functional imaging #415PS 24-03
functional mri #591PS 08-03#54
functional networks 102
functional ultrasound 191109109#237
functional ultrasound imaging PS 23-02
fungal biofilm #257
fungal infection #257
fungal infection model 129
fungal infections 179129
furimazine PS 08-02
gadolinium PS 01-02#409
galectin-3 PS 05-02101
gallium-68 177PS 05-03PS 08-07PS 08-02113127
gangliosides PS 09-03
gastrin-releasing peptide receptor 113
gastrointestinal 179PS 05-04104
gbm PS 06-04
gcp ii ligands PL 06
gd(dota) nanoconstructs #506
gd-aaztac17 #570
gdept 177PS 08-07
genetic reporter systems 104
giant #156
glial cells PS 01-05
glioblastoma PS 23-05PL 06125126#424
glioma PS 23-05
glp-1 receptor PS 09-07#336
glucose PS 23-03
glucose metabolism 128
glutamine PS 06-03
glutathione #165
glymphatic #413#421
glymphatic system 102
gold nanoclusters PS 05-04
gold nanoparticles 101111
gold-shell nps 105
good manufacturing practice 112
group beta streptococcus (gbs) 129
grpr 100
grpr-antagonist 113
gszs #462
gvhd 179104
halotag 128
hcc #495
head and neck cancer 192125
heart 130#686
heart failure #211PS 23-04PS 01-04
hemodynamics #405
hemoglobin #464
hepatitis 104
heptamethinecyanine fluorescent dyes #487
her2 PS 18-04
her3 PS 18-04
het-cam 192113
hetcam 113
heterocyclic-substituted bodipy derivatives #443
hgsoc PS 05-02
high field #305
high field mr #395
high field strength #391
high integration PS 22-03
high penetration depth PS 08-03
high rate pet PS 21-02
high resolution mri #357
high throughput imaging 111
histology PS 08-02
hne 179#178
hormones #591PS 08-03
hounsfield units 111
human carotid artery PS 23-04
humanized fab PS 05-02101
huntington's disease PL 05102
hybrid #314
hybrid imaging PS 01-03
hybrid microscopy #726
hybrid pixel detector PS 08-03
hybrid-imaging 172
hypercapnia #370
hyperglycemia 127
hyperoxia #370
hyperpolarization PS 06-04PS 06-04PS 23-03PS 23-03#427#465PS 02-06
hyperpolarized 178PS 23-03
hyperpolarized 13c 193PS 22-03#424#252PS 02-06
hyperpolarized mrsi #44PS 02-06
hyperpolarized nmr #557PS 02-06
hyperspectral 178PS 05-04
hypertension 139
hypoparathyroidism 111
hypoxia PS 23-04PS 08-07PS 09-02PL 07#404
idiopathic lung diseases PS 05-04
igdd #750
il-6 #461
illumination pattern PS 05-04
image derive arterial input function 193#457
image fusion PS 01-03
image processing 178PS 08-06111
image quality PS 01-06PS 22-03
image reconstruction 193PS 01-03PS 01-03PS 05-04#148#223
image registration 111
image-guided drug delivery PS 06-03125#570#159
image-guided therapy PS 01-04
imaging 178PS 05-02PS 05-02PS 23-03PS 23-03PL 07#404125129
imaging biomarkers PS 06-03PS 06-03
imaging guided biodistribution 127
imaging mass spectrometry PS 01-05
imaging processing PS 05-04
imaging tumour cell death PL 05
imatinib 191103
immune cell imaging 104
immune inflammation 104
immune system #657
immune-cell targeting #536#536
immuno-pet 192PS 05-03PS 09-07PL 07#631
immuno-theranostics #654
immunocompetent models 126
immunofluorescence 168
immunomodulation #33PS 21-03
immunopet PS 01-02PS 05-02PS 05-06#151#628
immunotherapy PS 19-03PS 09-07126
implant #54
implanted nmr microcoil PS 23-03
imultaneous pet/ct-uui system PS 21-02
in ovo 113
in silico modeling PL 06
in vitro 129
in vivo PS 09-07#409#59
in vivo bioluminescence 179129
in vivo cell tracking #13
in vivo clearance #583
in vivo confocal 129
in vivo fluorescence imaging #13#504
in vivo imaging PS 05-03#583
in vivo micropet 104
in vivo spectral unmixing #13
in vivo two-photon 129
in-loop 112
in-vivo PS 08-04139
in-vivo imaging PS 21-02
in-vivo x-ray imaging PS 02-02
indium-111 105
indocyanine green PS 06-05111
infarct PS 01-04
infection PS 05-06PS 08-02
infection imaging 130129129
infectious diseases 129
inflammation #211178179PS 06-04PS 23-04PS 08-04#320#321PS 09-02102104104130#178#13PS 01-04
inflammation imaging 191130
inflammtion PS 22-05
innate immunity #35
instruct-eric #723
insulinoma PS 09-07
integrin αvβ6 192PL 06
integrins 101
interness #588
interstitial-illumination PS 09-02
intra-operative imaging PS 05-02PS 23-07PS 23-07139
intranuclear PL 07
intraoperative 177PS 23-07PS 23-07
intraoperative imaging PS 05-02PS 24-02
intraperitoneal kainic acid rat model 102
intraperitoneal tumor model 139
intravital microscopy #536#536
intravital multiphoton microscopy 177PS 23-05
introductory lecture PS 05-03
introductory talk PS 23-07PS 08-07
inverse problems PS 01-03
inversion recovery 128
ionizing radiation 130
ipsc-nps 127
iron metabolism PL 06
iron oxide nanoparticles 179PL 06#77
ischemia 128
ischemia-reperfusion PS 21-03
ischemic stroke 102
kem 193111
kidney #44PS 02-06
kinetic modeling PS 06-04
kisspeptin 128
kit-based infection imaging 129
kp46 101
l-dopa induced dyskinesia PS 23-02
label-free PS 23-04
label-free molecular imaging PS 22-06
labeling PS 06-05126
lanthanide complexes #317
large stokes shift PS 06-05
large vessel vasculitis 103
laser spectroscopy PS 05-04
lc3 associated phagocytosis (lap) 129
ldl #570
led #466
leucine 102
life science research infrastructure #684
life sciences #687#751
lifetime of fluorescence #267
light sheet #585
light sheet fluorescence microscopy 125#472
light sheet microscopy #372
light-triggered drug delivery #127
line scanning PS 09-03
lipid PS 23-04
lipid metabolism #456
lipids PS 08-03PS 09-03PL 06
liposome labelling 112
liposomes PS 09-02#156#59
live-cell PS 22-06
liver PS 09-02#13#265
ln complexes 105
localistion 128
longitudinal in vivo micro-computed tomography 103
lorentzian fitting 111
low dose imaging PS 01-06
lps PS 08-03
lsfm PL 06#394#319
luciferin dose boost 179129
lung PS 08-06
lung ct PS 21-02
lung fibrosis #430
lung imaging #393#249
lung ventilation PS 08-03
lymph node staging PS 09-07
lymphadenectomy PS 05-02
macaca fascicularis #416
machine learning PS 05-02PS 08-07PS 08-06111127
maco 127
macrophage 130
macrophage mannose receptor 126
macrophage mannose receptor (mmr) 192126
macrophage polarization PL 06
macrophage profiling 126
macrophages 191192126126130
magnetic particle imaging 126
magnetic resonance fingerprinting #391
magnetic resonance imaging PS 21-03127#613PS 01-04
magnetic resonance spectroscopy 176PS 06-04127
magnetization transfer contrast #156
malaria PS 05-06
maldi PS 08-03#635
maldi-msi PS 23-04100
malignant melanoma PL 06
manganese PS 23-04#92#462
manganese complexes #558
manganese ferrite 105
manganese-52 112
mannose receptor PS 05-02
maps PL 06
mass spectrometry PS 01-05168
mass spectrometry imaging PS 06-04PS 09-03#708#635
material decomposition #255
mct1 PS 08-02
mcts #394
mdsfr/sff spectroscopy 111
mechanical force PL 06
mechanical ventilation PS 08-06
medical imaging PS 05-03
melanin #314
melanocytic nevi PL 06
melanoma PL 07100
memory PS 24-03
mesenchymal stem cells 128#512
mesoporous silica nanoparticles PS 06-05
metabolic PS 05-02
metabolic changes 127
metabolic disease #456
metabolic imaging PL 05#265
metabolic profiling PS 23-03
metabolism 176PS 22-03PS 06-04PS 06-04PS 06-04PS 23-03PS 23-03#427#618PS 02-06
metal airborne particles PS 05-04
metal doping 179#77
metallomics PS 05-03
metastases 192PL 06
mhtt PL 05
micro-ct PS 10-02PS 21-02PL 07#25#576
microalgae radiolabelling #45
microbubbles PS 05-02#127
microct PS 01-05PS 23-04#430#249
microct imaging #20
microfluidics PS 08-04112
microglia #301
micromechanics PS 08-06
micropet PS 01-05
micropet/ct PL 06
microscopy #726PS 05-04#267#314
microviscosity #267
mid-infrared PS 22-06
middle cerebral artery occlusion 102
milabs vect/or/ct PS 07-04
minflux PS 22-06
mitochondria 130
mitosis PL 06
mitoxantrone PS 06-05
mn2+ alternatives to gd3+ #588
modeling #421
models of sterile inflammation 104
moderate severity stroke model 191127
molecular design PS 05-06
molecular fluorescence guided imaging PS 23-07
molecular imaging 192PS 22-03PS 22-05PS 08-07100103119#415111#165
molecular modeling #301
molecular pet imaging PS 18-04
molecular rotors #267
molecular vectors 111
monoclonal antibodies #631
monocytes 104
monte carlo 111#585
monte carlo simulations #181
motion compensation PS 02-02
motion correction 193PS 21-02#457
motor task PS 23-02
mouse 191109
mouse model 191PS 05-06128128
mouse models #704
mpi 126
mpo #35
mr-angiography #374PS 05-06
mri #211#33192PS 01-02PS 01-03PS 01-05PS 01-05PS 22-03PS 23-06PS 18-06168PS 05-06PS 23-03PS 23-04PS 08-04PS 08-04#320PS 21-03PS 21-03PS 21-03PS 09-07#127PS 09-03100101101101102111111113113#413#421#416127128128128#464#558#317#216#156#506#329PS 24-03
mri cas #588
mri contrast agents 105#317
mri contrastagent #250
mri probes PS 08-04
mri signal amplification #250
mri-guided therapy 101
mri/pet dual probes 105
mrs PS 08-04PS 08-03104111
mrs and mri PS 23-03
mrsi 192193#424#212#252PS 02-06
msi #618#686
msot PS 04-04PS 08-03#404
multi modality imaging #357
multi-atlas 109
multi-modal imaging 168PS 08-03
multi-photon microscopy PS 24-03
multidrug resistance PL 06#275
multimodal imaging PS 07-04168PS 08-04PS 08-03#92#84100105#223#635
multimodal microscopy 168
multimodality #54
multimodality imaging 101
multiphoton microscopy #265
multipinhole spect 119119
multiple sclerosis 102128
multiplexed imaging #257
multiplexing PS 08-07
multispectral 177177PS 23-07PS 09-07
multispectral optoacoustic tomography PS 08-06
myelin 102128
myocardial imaging 119
myocardial infarction PS 09-02130PS 01-04
myocarditis 130
myocardium PS 23-04
nano-radiomaterials #40
nanobodies 192PL 07126126#654
nanobody 176PS 05-02PS 05-02
nanodiamonds 100
nanodroplets 176PS 06-05
nanofluorides PS 08-04
nanoluc complementation PS 08-02
nanomedicine #536PS 06-03#536#40125#159
nanomedicines 125
nanomicelles PS 08-04
nanomotors PS 05-03
nanoparticle PL 07PL 06#628
nanoparticle delivery PL 06#275
nanoparticle labeling 105
nanoparticles PS 08-04105105113#233
nanovesicles #112
nash #495104
near infrared #440#585
near infrared optical tomography #223
near-infrared fluorescence PS 05-02
near-infrared fluorescence imaging 139
near-infrared imaging 103
near-infrared probe PS 06-05
necrosis 177PS 06-03
necrosis imaging 112
neoadjuvant therapy PS 09-07
neocardina #372
network analysis #461
network stabilization 191127
neurobehavior 127
neuroblastoma PS 09-07
neurodegeneration 109
neuroendocrine tumors #700
neuroimaging 176191PS 01-05172PS 06-04102109PS 24-03PS 24-03
neuroinflammation PS 01-05PS 09-03#301
neuron cells 109
neuronal cell cultures 127
neuropeptides 128
neuroprotection PS 21-03
neuroradiology PS 01-05
neurotensin 177PS 08-02113113
neurovascular coupling PS 23-02PS 24-03
nevi 100
new tracer 113
nir-ii contrast agent PS 08-07
nirf PS 23-07#151
nitrosative stress 130
nk1 receptors 127
nmrd 176PS 08-04
nodal metastasis PS 23-07
non-invasive PS 09-02
non-invasive imaging PS 09-03128
non-linear imaging #385
nonhuman primate 129
novel pre-clinical imaging applications PS 07-04
novel theranostic probes #216
nsclc 113
ntr 177PS 08-07
ntsr1 100
nuclear imaging 104139
nuclear medicine PS 22-05
nuclear morphology 111
numerical simulation PS 05-04
oatp PS 06-05
occupational exposure PS 05-04
oncocardiology 130
oncology PS 24-02
onolytic virus PS 08-02
open access #687#688
open access policy #726
optical PS 01-05#249
optical clearing #329
optical control PS 05-06
optical imaging 179PS 05-04PS 08-02#84100105#181#440#267PS 24-02
optical imaging fluorophores 192101
optical imaging probe 139
optical molecular imaging PS 08-02
optical projection tomography #472
optics PS 05-04
optimization PS 05-04
opto-acoustic 100
optoacoustic PS 06-03PS 08-03PS 09-02
optoacoustic bio-imaging PS 04-04
optoacoustic imaging PS 23-05103#456
optoacoustic microscopy PS 22-06
optoacoustic techniques #405
optoacoustic tomography PS 06-03109#404128
optoacoustics 193PS 08-07PS 08-06#58#415#360
optogenetics PS 09-03PS 09-03
orthotopic glioblastoma model PL 06
orthotopic mouse model 125
orthotopic xenograft PS 05-02
osem PS 01-03
osimertinib 113
ovarian cancer PL 07PL 06101125#714
oxidative stress 130
oxidized low-density lipoprotein 103
oxygen #464
oxygenation #415
oxygenation-sensitive mri #370
p-selectin 178#321PS 09-02104
p2y12 receptor #301
paclitaxel #570
paediatric 111
pah PS 23-04
pain chronification #461
palmitic acid #206
pan-cancer 100
pancreas PS 08-02
pancreatic cancer 179192PS 08-02PL 07PL 06113139
pancreatic ductal adenocarcinoma PS 06-03
paracest #317
parahydrogen PS 23-03
parallel transmit rf coil arrays PS 23-03
parathyroid hyperplasia 112
parkinson's disease PS 01-05PS 23-02128
parkinson`s disease PL 05
parp 192100#163
partial volume effect correction 193#457
partial wave spectroscopy PL 07
pathogenesis PS 05-06
pathomechanism 130
patient-derived xenograft PS 05-02
patient-derived xenografts PS 23-05
pd-l1 176PS 18-04PS 05-02
pdac 192193113#212#252PS 02-06
pdac cancer PL 07
peg-spacer 113
pentixafor PS 22-05
pentixather PS 22-05
perfusion 112#404
peripheral arterial disease #405
peripheral vascular disease #405
peristaltism PL 06
permeability #57
perylene diimide PS 06-05
pet #211177177191191192192192PS 01-03PS 01-05PS 01-05PS 22-03PS 22-05PS 22-05PL 05168PS 23-05PS 05-03PS 05-03PS 06-04PS 06-03PS 06-03PS 23-04PS 08-03PS 08-03#320#495PS 08-02PS 09-07PS 09-03PL 07PL 07PL 06100100102103112112113113128128130130129#212#59#45#512#714#618
pet imaging 176176179179PS 01-05PL 05PS 05-02PS 05-03PS 23-02PS 23-04#35PS 09-07PL 07100112113113#301128139#336#205
pet imaging. PS 05-03
pet infection imaging 129
pet tracer 128
pet-ct 179PS 08-03129#291
pet-mr PS 21-02
pet-mri 172PS 05-02PS 21-03128
pet/ct 177192192193PS 01-03PS 01-06PS 08-07PL 06100104119126
pet/ct imaging #536#536
pet/ct-imaging PS 05-02
pet/fmri PS 23-02
pet/mr 193PS 01-03PS 21-02111
pet/mri 176193PS 01-06PS 22-03PS 22-03172PS 08-03PS 08-02#303104105105119
pet/spect PL 07PL 07
ph imaging 111#613#44PS 02-06
ph sensor #317
phantom PS 09-02#360
phantoms #560
pharmacokinetic 111
pharmacokinetics 179PS 06-03#291
pharmacology 191109
phase contrast imaging PS 21-02PS 02-02
phase i 192126
phase iii PS 24-02
phase iii studies #647
phase mapping PS 21-03
phase retrieved tomography #472
phase-contrast 109
phasecontrast PS 08-02
phenotyping #704
phosphine 112
phospolipids PS 08-04
photo-cidnp #465
photo/optoacoustic 126
photoacoustic PS 06-05#466#440#314
photoacoustic imaging 178PS 06-05PS 08-06PS 09-02#560#150
photoacoustic imaging. PS 09-02
photoacoustics 193PS 09-02103#58#415#456
photocage #67
photochemistry PS 05-03
photocontrollable proteins PS 08-07
photodynamic therapy PS 06-03#132125125
photoimmunotherapy PS 23-05
photon counting PS 02-02
photon-counting #25
photon-counting micro-ct #255
photopharmacology PS 05-06
photoradiolabelling 176PS 05-03
photosensitizer 125
pituitary adenoma 177PS 23-07
pla-nanoparticles #216
placenta #464
plasmodium PS 05-06
platform #151
plga #583
polarization second harmonic generation 100
polarization sensitive shg 128
polidentate chelators 179112
poly-histidine 103
polychromatic 193#148
polymer contrast agent #613
polymer-in-oil material PS 09-02
polymeric nanoparticles PS 08-04
polypept(o)ide stars 125
polypyrrole nanoparticles #150
porphyrins 112
positon emission tomography 102
positron emission tomography PS 01-05PS 01-06PS 08-07#84PL 06104112113#263128130
pre-clinical 127
pre-resonance 178PS 05-04
precision medicine PS 23-05125
preclincal imaging #658
preclinical PS 01-06PS 22-03111
preclinical computed tomograpy 111
preclinical imaging 193PS 05-04PS 06-05105119
preclinical pet PS 08-06PS 21-02
preclinical pet insert PS 21-02
preclinical spect 119
preclinical studies #263
preclinical trials 125
pretargeting 192PL 07
primate PS 23-02
probe chemistry #395
probes PS 05-03
projections #319
prostae & pancreas #462
prostate cancer PS 23-07100101113#700
proste cancer 100
protein synthesis rate 102
proteins PS 09-02
proton therapy 176PS 06-05
prrt 101
psma 172PL 06100101105113#700
pulmonary airways 178PS 21-02
pulmonary arterial hypertension PS 23-04
pulmonary fibrosis #576
pulmonary hypertension #205
pyclen derivatives #558
q175 mouse model 102
quality control PS 01-06
quantification 193PS 08-06119111
quantitation 139
quantitative mri #391
quantitative photoacoustic tomography #360
quantitave 193#148
quasi-periodic patterns 102
radiation-induced nucleation theory 176PS 06-05
radio-contrast agents #222
radio-iodine PS 01-02
radiochemistry PS 05-03PS 08-07#59#407
radiofluorination 179112
radiofrequency ablation PS 09-02
radiolabeling 105113
radiometal PS 01-02
radiomics 103
radionuclide PS 23-07
radionuclide imaging PS 01-02
radionuclide therapy 101
radionuclides PS 01-06
radiosynthesis #346
radiotracer PS 05-06
radiotracers PS 01-05
range verification 176PS 06-05
rasp PS 09-02
rat PS 23-02PS 23-04PS 08-03128
ratiometry PS 08-04
recombinant proteins 103
recovery 191102
rectal cancer 172
redox-sensitive #165
regularization PS 05-04
relaxivity PS 01-02
remote ischemic conditioning PS 21-03
remyelination 191#46
renal PS 23-03
reporter gene 128
reporter genes PS 18-06
reporting PS 01-06
research infrastructure #688#723#704#726
research infrastructures #687#751
resistance PL 07#714
resolution modeling PS 01-03
respiratory gating PS 22-03
respiratory system 103
response to therapy 177PS 06-03
responsive agents #462
responsive contrast agent #11
resting state 191PS 23-02PS 08-03109109#461
resting state fmri #325191PS 23-02PS 08-03127
resting state functional mri 102
retention #409
retina 128
rf coil design #305
rhenium 112
rheumatoid arthritis #132
rhodobacter 126
riboflavin 125
rnaseq PL 06
rodent 109
ros #35112
rotenone mouse model of parkinson's disease 102
rs-fmri 191#46
rsfmri 102
s. aureus 130
safir PS 21-02
sah 127
sample collection PL 06
scaffold characterization 128
scinitgraphic #233
scintillator crystal 119
segmentation 109111
selective targeting 105
semiquantification PS 08-06
sensory stimulation 109
serotonin transporter PS 23-02
sgm-101 PS 24-02
shift reagent PS 06-04
short term modulation PS 23-02
shortwave infrared fluorescence PS 05-04
siderophore 129
siderophores 129
sigma-1 receptor PL 06
signal processing PS 01-03
silica nanoparticles 105
simulation #585
simulations 111
simultaneous PS 22-03
simultaneous 3pef and 2pef microscopy 109
simultaneous pet-mri PS 22-03
simultaneous pet/ct-uui system 193#457
simultaneous pet/mri PS 22-03105
single molecule localization PS 22-06
single molecule tracking PS 22-06
single voxel 1h spectroscopy 127
single-domain antibody 139
site-specific 176PS 05-02#151
site-specific bioconjugation 103
skin cancer PL 06
sliding window analysis 102
slow waves PS 09-03PS 09-03
small animal PS 01-06
small animal imaging PS 01-06#690
small animal mri #305
small animal pet PS 21-02
small molecule donor #67
small molecules #749
small-animal imaging 119
small-animal spect 119
smart contrast agent #395
smart probes #588
smartphone ophthalmoscope 109
smartprobe 179#178
smartprobes #257
sodium PS 23-03
software-pipeline 172
somatostatin receptor PS 23-07
sonopermeation 192125
sonoporation 101
spect 179PS 01-03PS 01-06PS 07-04PS 08-07105112112
spect/ct 192PS 01-03PS 08-03PL 06104111
spect/ct imaging #233
spect/mri #374PS 05-06
spectroscopic ct PS 08-03
spectroscopy 176PS 06-04PS 09-02
speed-of-sound #401
spheroids PL 07PL 07101
spill-in effect PS 08-06
spim #319#372
spinal cord injury 128
spion 105
spline 111
spm PS 08-06
spondyloarthritis 104
sstr #700
stability #588
standardisation #560
standardization #658#690
staphylococcus aureus PS 05-06
stem cells PS 23-06PS 06-05105105
stent graft infections 129
stimulated raman scattering 178PS 05-04
strain PS 08-06
stroke #33191PS 06-04PS 21-03PS 21-03102109127127
stroke model PS 21-03
stroke-induced hyperconnectivity 191127
study group #738PS 24-04PS 24-04PS 24-04PS 24-04
su5416 PS 23-04
subarachnoid haemorraghe 127
subcutaneous tumor xenografts #329
sultone PL 07
super resolution PS 06-05
super resolution fluorescence imaging PS 22-06
super resolution in cardiac pet PS 21-02
super resolution optical microscopy PS 22-06
super-resolution microscopy 129
superparamagnetic nanoparticles 105
superresolution 178PS 09-03
surgical imaging PS 24-02
surgical inovation PS 24-02
surgical margin assessment 193#197
susceptibility-weighted imaging PS 21-03
sv2a 191128
swir imaging PS 08-07
synaptic density 191102128
synchrotron imaging #393
synchrotron radiation 178PS 21-02PS 21-02
synthesis PS 06-05
synthesis and characterization #443
synthetic biology PS 18-06
synuclein #222
system performance PS 01-06
system xc- PS 08-07
t-cell lymphoma PS 06-04
t1 contrast 179#77
t1-mri #40
t1-weighted 3d mr 127
takotsubo syndrome 130
tam 126
target-to-background ratio (tbr) PS 08-06
targeted 105
targeted alpha-particle therapy 101
targeted drug delivery PS 23-03125
targeted hyperthermia PS 23-03
targeting PS 08-04105#156
tau PS 01-05PS 21-03
tc-99m 130
tca cycle #557PS 02-06
technetium-99 112
technical validation PS 09-02
temporal lobe epilepsy 102
tetrazoles PS 05-03
tgf-beta PS 18-04
thalamus #416
thallium #407
theranostic PS 07-04125
theranostic agents 105
theranostic probes 192101
theranostics 179PS 22-05PS 22-05172PS 05-06PL 07105125#748#700#747#749
therapeutic biologicals #631
therapy 127
thermogenic activator PS 06-04
third harmonic generation 100
third harmonic generation (thg) #385
thn201 #237
thp #59
thrombectomy PS 21-03
thyroid cancer PS 05-02PS 23-07101
thyroid surgery 111
time-lapsed tomography PS 01-06
tissue distribution 193119
tissue implants 176PS 08-04
tissue-mimicking material PS 09-02
tof-kem 193111
tof-pet 193119111
tof-sims #265
toll-like receptors 102
tomographic microscopy #319
tomographic optical and morphological imaging PS 08-02
tomography 193PS 08-02#58#401
translational 111
translational imaging PS 21-03
translational medicine #684
translational research #25
transparent pet PS 22-03
transverse electron microscopy 105
treatment response PS 06-03
trifluoromethylation #346
trigger-responsive PS 01-02
trimodal nanosystems 105
tris (8-hydroxyquinolinato) gallium (iii) 101
tsne PS 08-03
tspo 179PS 08-06130139
tumor 126
tumor acidosis 176#303#613
tumor imaging 113
tumor invasion 177PS 23-05
tumor markers 139
tumor microenviroment #329
tumor microenvironment 177PS 23-05PS 23-05PL 06125#159
tumor microenvironment heterogeneity PL 06#275
tumor microenvironment ph PS 08-07
tumor profil PL 06
tumor targeting PS 06-03
tumor-associated macrophages 126
tumor-associated-macrophage 126
tumor-homing phagocytes #536#536
tumors PS 05-02
tumour 178PS 23-03PL 06111
tumour microenvironemnt PS 06-04
tumour vascularisation PL 06
tuning photophysical properties #443
turbid media PS 05-04
two-photon microscopy PS 24-03
u-spect5 e-class 119
ucb-h 102
ultra-high field mri PS 23-03
ultrafast imaging 178PS 09-03
ultrafast ultrasound PL 06
ultrafast ultrasound imaging 130
ultrasmall nanoprobes 105
ultrasound 178178PS 18-06168PS 05-02#127PS 09-03PS 09-02PS 09-02101#401#466PS 24-03PS 24-03
ultrasound image processing 100
ultrasound imaging 139PS 01-04
ultrasound molecular imaging 178#321PS 09-02
ultrasound therapy 101
ultrasound-guided injection PL 07
usmb 192125
uspio PS 09-07
validation 111
vap-1 130
vascular disorder PS 05-04
vascular permeability #506
vasculature PS 23-05
vasoreactivity #370
vector PS 01-02
vector6 pet PS 07-04
vessels PL 06
vevolazr-x PL 07125
vhh PS 08-07
viability PS 23-04
volumetric imaging PS 24-03
voxel-by-voxel analysis PS 08-03
water-soluble aza-bodipy PS 08-07
welcome #745
western diet PS 08-03
white matter #416
white matter hyperintensities 111
whole body PS 01-06
x-nuclei #305
x-ray PS 08-02
x-ray & optical ct PS 07-04
x-ray computed tomography 178PS 21-02
x-ray imaging 111PS 02-02
x-ray imaging study group PS 02-02
x-ray tomography 193PS 22-06109#148
xenograft 192113
xlf #430
yia PS 11-06
zebrafish PS 21-02#20
zinc sensors #462
zirconium-89 176PS 05-03#628#631
zirconium[89] PS 05-06
zymonic acid #44PS 02-06
α1-microglobulin 101
α4β2 nicotinic acetylcholine receptor 102
fluorescence microscopy 105